This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Merck Patent Gmbh. Active years: 2012-2017.
Company Filing History:
Years Active: 2012-2017
Title: Wolf-Meinhard Becker: Innovator in Allergy Research
Introduction
Wolf-Meinhard Becker is a notable inventor based in Mozen, Germany. He has made significant contributions to the field of allergy research, particularly in the development of recombinant allergens. With a total of 3 patents, Becker's work has the potential to improve the diagnosis and treatment of pollen allergies.
Latest Patents
Becker's latest patents focus on the DNA sequence and preparation of grass pollen allergen Phl p 4 by recombinant methods. The first patent relates to the preparation and use of recombinant variants of group 6 allergens of true grasses. These variants are characterized by reduced IgE reactivity compared to known wild-type allergens while retaining substantial reactivity with T-lymphocytes. The second patent provides the genetic sequence of the major grass pollen allergen Phl p 4. This invention also covers fragments, new combinations of partial sequences, and point mutants that exhibit hypoallergenic action. The recombinant DNA molecules and derived polypeptides can be utilized for the therapy of pollen-allergic diseases. Additionally, the proteins prepared by recombinant methods can be employed for both in vitro and in vivo diagnosis of pollen allergies.
Career Highlights
Wolf-Meinhard Becker is associated with Merck Patent GmbH, where he continues to advance his research in allergen development. His innovative work has positioned him as a key figure in the field of allergy treatment.
Collaborations
Becker has collaborated with notable colleagues such as Helmut Fiebig and Andreas Nandy, contributing to the advancement of allergy research through teamwork and shared expertise.
Conclusion
Wolf-Meinhard Becker's contributions to the field of allergy research through his patents and collaborations highlight his role as an innovator. His work has the potential to significantly impact the diagnosis and treatment of pollen allergies, showcasing the importance of innovation in medical science.